Neurobiology of Aging
Volume 29, Issue 4 , Pages 524-541 , April 2008

Translational gene mapping of cognitive decline

  • Beth Wilmot

      Affiliations

    • Department of Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, OR, United States
    • Corresponding Author InformationCorresponding author at: Department of Molecular and Medical Genetics, L103, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States. Tel.: +1 503 494 4362; fax: +1 503 494 7499.
    • ,
  • Shannon K. McWeeney

      Affiliations

    • Division of Biostatistics, Department of Public Health and Preventive Medicine, Oregon Health and Sciences University, Portland, OR, United States
    • ,
  • Randal R. Nixon

      Affiliations

    • Department of Pathology, Oregon Health and Sciences University, Portland, OR, United States
    • ,
  • Thomas J. Montine

      Affiliations

    • Department of Pathology, University of Washington, Seattle, WA, United States
    • ,
  • Jamie Laut

      Affiliations

    • Department of Neurology, Oregon Health and Sciences University, Portland, OR, United States
    • ,
  • Christina A. Harrington

      Affiliations

    • Gene Microarray Shared Resource, Oregon Health and Sciences University, Portland, OR, United States
    • ,
  • Jeffrey A. Kaye

      Affiliations

    • Department of Neurology, Oregon Health and Sciences University, Portland, OR, United States
    • ,
  • Patricia L. Kramer

      Affiliations

    • Department of Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, OR, United States
    • Department of Neurology, Oregon Health and Sciences University, Portland, OR, United States

Received 25 April 2006 ,Revised 14 November 2006 ,Accepted 16 November 2006.

References 

  1. Anon., 1997. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's disease. Neurobiol. Aging 18 (4 Suppl.), S1–S2.
  2. Bannai H, Fukatsu K, Mizutani A, Natsume T, Iemura S, Ikegami T, et al. An RNA-interacting protein, SYNCRIP (heterogeneous nuclear ribonuclear protein Q1/NSAP1) is a component of mRNA granule transported with inositol 1,4,5-trisphosphate receptor type 1 mRNA in neuronal dendrites. J. Biol. Chem. 2004;279(51):53427–53434
  3. Beissbarth T, Speed TP. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics. 2004;20(9):1464–1465
  4. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Annal. Stat. 2001;29(4):1165–1188
  5. Bernardini S, Bellincampi L, Ballerini S, Federici G, Iori R, Trequattrini A, et al. Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin. Chem. 2005;51(6):944–951
  6. Bertram L, Tanzi RE. Alzheimer's disease: one disorder, too many genes?. Hum. Mol. Genet. 2004;13(Spec No. 1):R135–R141
  7. Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch. Neurol. 1995;52(1):81–88
  8. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor Suppressor responses. Proc. Natl. Acad. Sci. USA. 2004;101(7):2173–2178
  9. Braak H, Braak E. Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J. Neural. Trans. 1998;105(8–9):801–819
  10. Carey RM, Balcz BA, Lopez-Coviella I, Slack BE. Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein. BMC Cell. Biol. 2005;6:30
  11. Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 2000;157(1):277–286
  12. Cheung VG, Jen KY, Weber T, Morley M, Devlin JL, Ewens KG, et al. Genetics of quantitative variation in human gene expression. Cold Spring Harb. Symp. Quant. Biol. 2003;68:403–407
  13. Chyung JH, Selkoe DJ. Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface. J. Biol. Chem. 2003;278(51):51035–51043
  14. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 2002;70(3):462–473
  15. Dallas PB, Gottardo NG, Firth MJ, Beesley AH, Hoffmann K, Terry PA, et al. Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR–how well do they correlate?. BMC Genomics. 2005;6(1):59
  16. de la Monte SM, Wands JR. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J. Alzheimers Dis. 2005;7(1):45–61
  17. Dimakopoulos AC. Protein aggregation in Alzheimer's disease and other neuropathological disorders. Curr. Alzheimer Res. 2005;2(1):19–28
  18. Dresios J, Aschrafi A, Owens GC, Vanderklish PW, Edelman GM, Mauro VP. Cold stress-induced protein Rbm3 binds 60S ribosomal subunits, alters microRNA levels, and enhances global protein synthesis. Proc. Natl. Acad. Sci. USA. 2005;102(6):1865–1870
  19. Dudoit S, Yang Y, Callow M, Speed T. Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Statistica Sinica. 2002;12:111–139
  20. Dunckley T, Beach TG, Ramsey KE, Grover A, Mastroeni D, Walker DG, et al. Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol. Aging. 2005;
  21. Farrall M. Quantitative genetic variation: a post-modern view. Hum. Mol. Genet. 2004;13(Suppl. 1):R1–R7
  22. Fathallah-Shaykh HM. Microarrays: applications and pitfalls. Arch. Neurol. 2005;62(11):1669–1672
  23. Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307–315
  24. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80
  25. Hegde AN. Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity. Prog. Neurobiol. 2004;73(5):311–357
  26. Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res. 2006;312(2):184–197
  27. Hsu YC, Perin MS. Human neuronal pentraxin II (NPTX2): conservation, genomic structure, and chromosomal localization. Genomics. 1995;28(2):220–227
  28. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18(Suppl. 1):S96–S104
  29. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31(4):e15
  30. Jais PH. How frequent is altered gene expression among susceptibility genes to human complex disorders?. Genet. Med. 2005;7(2):83–96
  31. Kanai Y, Dohmae N, Hirokawa N. Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron. 2004;43(4):513–525
  32. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 1988;23(2):138–144
  33. Keating DJ, Chen C, Pritchard MA. Alzheimer's disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN1. Ageing Res. Rev. 2006;
  34. Kita H, Carmichael J, Swartz J, Muro S, Wyttenbach A, Matsubara K, et al. Modulation of polyglutamine-induced cell death by genes identified by expression profiling. Hum. Mol. Genet. 2002;11(19):2279–2287
  35. Layfield R, Lowe J, Bedford L. The ubiquitin-proteasome system and neurodegenerative disorders. Essays Biochem. 2005;41:157–171
  36. Lee JH. Genetic evidence for cognitive reserve: variations in memory and related cognitive functions. J. Clin. Exp. Neuropsychol. 2003;25(5):594–613
  37. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 2001;20(11):683–695
  38. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 1999;285(5429):895–898
  39. Marshall E. Getting the noise out of gene arrays. Science. 2004;306(5696):630–631
  40. Martin KC, Kosik KS. Synaptic tagging—who's it?. Nat. Rev. Neurosci. 2002;3(10):813–820
  41. Mattick JS, Makunin IV. Small regulatory RNAs in mammals. Hum. Mol. Genet. 2005;14(Spec No. 1):R121–R132
  42. McPherson PS, Kay BK, Hussain NK. Signaling on the endocytic pathway. Traffic. 2001;2(6):375–384
  43. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41(4):479–486
  44. Mizutani A, Fukuda M, Ibata K, Shiraishi Y, Mikoshiba K. SYNCRIP, a cytoplasmic counterpart of heterogeneous nuclear ribonucleoprotein R, interacts with ubiquitous synaptotagmin isoforms. J. Biol. Chem. 2000;275(13):9823–9831
  45. Mohney RP, Das M, Bivona TG, Hanes R, Adams AG, Philips MR, et al. Intersectin activates Ras but stimulates transcription through an independent pathway involving JNK. J. Biol. Chem. 2003;278(47):47038–47045
  46. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS, et al. Genetic analysis of genome-wide variation in human gene expression. Nature. 2004;430(7001):743–747
  47. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur. J. Nucl. Med. Mol. Imaging. 2005;32(4):486–510
  48. O’Bryan JP, Mohney RP, Oldham CE. Mitogenesis and endocytosis: What's at the intersection?. Oncogene. 2001;20(44):6300–6308
  49. Ohki-Hamazaki H, Watase K, Yamamoto K, Ogura H, Yamano M, Yamada K, et al. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature. 1997;390(6656):165–169
  50. Ohki-Hamazaki H, Iwabuchi M, Maekawa F. Development and function of bombesin-like peptides and their receptors. Int. J. Dev. Biol. 2005;49(2–3):293–300
  51. Ohtsuka T, Hata Y, Ide N, Yasuda T, Inoue E, Inoue T, et al. nRap GEP: a novel neural GDP/GTP exchange protein for rap1 small G protein that interacts with synaptic scaffolding molecule (S-SCAM). Biochem. Biophys. Res. Commun. 1999;265(1):38–44
  52. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45
  53. Predescu SA, Predescu DN, Timblin BK, Stan RV, Malik AB. Intersectin regulates fission and internalization of caveolae in endothelial cells. Mol. Biol. Cell. 2003;14(12):4997–5010
  54. Pucharcos C, Estivill X, de la Luna S. Intersection 2, a new multimodular protein involved in clathrin-mediated endocytosis. FEBS Lett. 2000;478(1–2):43–51
  55. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 2003;339(1):62–66
  56. Salehi A, Delcroix JD, Swaab DF. Alzheimer's disease and NGF signaling. J. Neural Transm. 2004;111(3):323–345
  57. Savdie C, Ferguson SS, Vincent JP, Beaudet A, Stroh T. Cell-type-specific pathways of neurotensin endocytosis. Cell Tissue Res. 2005;1–17
  58. Scarmeas N, Stern Y. Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr. Neurol. Neurosci. Rep. 2004;4(5):374–380
  59. Scearce LM, Brestelli JE, McWeeney SK, Lee CS, Mazzarelli J, Pinney DF, et al. Functional genomics of the endocrine pancreas: the pancreas clone set and PancChip, new resources for diabetes research. Diabetes. 2002;51(7):1997–2004
  60. Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging. 2005;
  61. Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. Preclinical” AD revisited: neuropathology of cognitively normal older adults. Neurology. 2000;55(3):370–376
  62. Singleton A, Myers A, Hardy J. The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. Hum. Mol. Genet. 2004;13(Spec No. 1):R123–R126
  63. Smyth G. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004;3(1):1–23
  64. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J. Int. Neuropsychol. Soc. 2002;8(3):448–460
  65. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA. 2003;100(16):9440–9445
  66. Stroombergen MC, Waring RH. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum. Exp. Toxicol. 1999;18(3):141–145
  67. Sun-Wada GH, Wada Y, Futai M. Diverse and essential roles of mammalian vacuolar-type proton pump ATPase: toward the physiological understanding of inside acidic compartments. Biochim. Biophys. Acta. 2004;1658(1–2):106–114
  68. Team RDC, 2005. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, http://www.R-project.org.
  69. Tong XK, Hussain NK, Adams AG, O’Bryan JP, McPherson PS. Intersection can regulate the Ras/MAP kinase pathway independent of its role in endocytosis. J. Biol. Chem. 2000;275(38):29894–29899
  70. Tsui CC, Copeland NG, Gilbert DJ, Jenkins NA, Barnes C, Worley PF. Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity. J. Neurosci. 1996;16(8):2463–2478
  71. Wellmann S, Buhrer C, Moderegger E, Zelmer A, Kirschner R, Koehne P, et al. Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism. J. Cell Sci. 2004;117(Pt 9):1785–1794
  72. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW. Allelic variation in human gene expression. Science. 2002;297(5584):1143
  73. Yao PJ, Zhu M, Pyun EI, Brooks AI, Therianos S, Meyers VE, et al. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol. Dis. 2003;12(2):97–109

PII: S0197-4580(06)00434-9

doi: 10.1016/j.neurobiolaging.2006.11.008

Neurobiology of Aging
Volume 29, Issue 4 , Pages 524-541 , April 2008

Article Tools

* Image Usage & Resolution